Ella Korets-Smith, Chief Business Officer Oct. 13 | 2:00pm | BlueRock Therapeutics Ontario, Canada (Private) In-person Presentation Virica Biotech is the first company to develop and commercialize a unique small-molecule platform of over 100 patent-protected compounds, called Viral Sensitizers, to solve fundamental development challenges facing the viral medicine industry such...

Jan Jensen, Ph.D., CEO Oct. 14 | 11:15am | BlueRock Therapeutics Ballroom Cleveland, OH (Private) In-person Presentation Trailhead Biosystems is building specialized human cells of multiple types, addressing multiple indications. Our lead programs are directed towards diabetes, blood disorders and bone marrow transplantation, and CNS diseases. The company is the...

Suyash Prasad, Chief Medical Officer and Head of Research and Development Oct. 12 | 2:30pm | AVROBIO Ballroom Dallas, TX (NASDAQ: TSHA) In-person Presentation Taysha Gene Therapies is on a mission to eradicate monogenic central nervous system disease. With a singular focus on developing curative medicines, we aim to rapidly...

Geoff Hamilton, Co-Founder and CEO Oct. 14 | 11:30am | BlueRock Therapeutics Ballroom San Diego, CA (Private) In-person Presentation Stemson Therapeutics is a preclinical-stage cell therapy company founded in 2018 with a mission to cure hair loss by leveraging the regenerative power of induced pluripotent stem cells (iPSCs). Stemson uses...

Stephane Boissel, CEO Oct. 13 | 11:45am | BlueRock Therapeutics Ballroom Paris, France (Private) In-person Presentation SparingVision is a genomic medicines company translating pioneering science into vision-saving treatments. Founded to advance over 20 years of world-leading ophthalmic research from its scientific founders at the Paris Vision Institute, SparingVision is leading...

Rogerio Vivaldi, M.D., President and CEO Oct. 13 | 2:30pm | AVROBIO Ballroom Cambridge, MA (NASDAQ: SGTX) In-person Presentation Sigilon Therapeutics seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform. Sigilon’s product candidates are non-viral engineered cell-based therapies designed to produce the crucial proteins, enzymes,...

Dan Kaufman, M.D., Ph.D., Co-Founder and Chief Science Officer Oct. 12 | 3:00pm | BlueRock Therapeutics Ballroom San Diego, CA (Private) In-person Presentation Shoreline Biosciences develops genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer and macrophage products that are intelligently designed for greater potency and persistence. With our...

Atta Behfar, M.D., Ph.D., CEO Oct. 13 | 4:30pm | BlueRock Therapeutics Ballroom Rochester, MN (Private) In-person Presentation Rion is a clinical-stage regenerative medicine company developing innovative exosome therapeutics to be clinically impactful and broadly accessible. The company has developed Purified Exosome Product (PEP), a biologic platform that harnesses the...

Noah Davidsohn, Ph.D., Chief Science Officer Oct. 13 | 5:15pm | BlueRock Therapeutics Ballroom San Diego, CA (Private) In-Person Presentation Rejuvenate Bio is creating a revolutionary approach to full age reversal. Aging is caused by the dysregulation of multiple systems in the body that manifest itself in age related...

Helen Sabzevari, Ph.D., President and CEO Oct. 13 | 4:45pm | AVROBIO Ballroom Germantown, MD (NASDAQ: PGEN) In-person Presentation Precigen is a dedicated discovery and clinical-stage biopharmaceutical company advancing the next-generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core...

By using this website you agree to accept our Privacy Policy and Terms & Conditions